Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$991M |
| 2 |
Broadcom
AVGO
|
+$941M |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$859M |
| 4 |
Amazon
AMZN
|
+$858M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$425M |
| 2 |
Merck
MRK
|
+$379M |
| 3 |
ASML
ASML
|
+$336M |
| 4 |
Yum China
YUMC
|
+$311M |
| 5 |
Microchip Technology
MCHP
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Financials | 12.43% |
| 3 | Industrials | 11.73% |
| 4 | Healthcare | 10.66% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Biomea Fusion
BMEA
$88.2M
| $113K | ﹤0.01% |
11,191
-502
| -4% | -$3.26K |
|
3502
Viemed Healthcare
VMD
$447M
| $111K | ﹤0.01% |
15,085
-77,481
| -84% | -$553K |
|
3503
Fulcrum Therapeutics
FULC
$241M
| $109K | ﹤0.01% |
30,662
-381
| -1% | -$2.83K |
|
|
PHLT
3504
DELISTED
Performant Healthcare Inc
PHLT
| $109K | ﹤0.01% |
29,112
-43,830
| -60% | -$150K |
|
3505
Spire Global
SPIR
$408M
| $109K | ﹤0.01% |
10,886
+122
| +1% | +$1.27K |
|
3506
Mizuho Financial
MFG
$120B
| $108K | ﹤0.01% |
25,878
+611
| +2% | +$2.55K |
|
|
HSHP
3507
Himalaya Shipping
HSHP
$689M
| $108K | ﹤0.01% |
12,482
-10,822
| -46% | -$85.9K |
|
3508
EyePoint Inc
EYPT
$999M
| $108K | ﹤0.01% |
13,480
-217
| -2% | -$1.91K |
|
3509
Zevra Therapeutics
ZVRA
$578M
| $107K | ﹤0.01% |
15,377
-255
| -2% | -$1.73K |
|
3510
Wheels Up
UP
$203M
| $106K | ﹤0.01% |
2,189
+25
| +1% | +$1.22K |
|
3511
Lindblad Expeditions
LIND
$1.95B
| $105K | ﹤0.01% |
11,402
-22,517
| -66% | -$209K |
|
|
MRSN
3512
DELISTED
Mersana Therapeutics
MRSN
| $105K | ﹤0.01% |
2,219
+417
| +23% | +$18.4K |
|
|
NOTV
3513
DELISTED
Inotiv
NOTV
| $104K | ﹤0.01% |
61,339
+270
| +0.4% | +$457 |
|
3514
Arteris
AIP
$1.24B
| $104K | ﹤0.01% |
13,467
+151
| +1% | +$1.17K |
|
3515
ADC Therapeutics
ADCT
$140M
| $103K | ﹤0.01% |
32,669
-290
| -0.9% | -$915 |
|
3516
Heron Therapeutics
HRTX
$93.4M
| $103K | ﹤0.01% |
51,661
+10,336
| +25% | +$24.7K |
|
3517
Virgin Galactic
SPCE
$315M
| $103K | ﹤0.01% |
16,821
-269
| -2% | -$1.8K |
|
3518
Codexis
CDXS
$158M
| $103K | ﹤0.01% |
33,304
+2,547
| +8% | +$7.88K |
|
3519
Lexicon Pharmaceuticals
LXRX
$1.03B
| $102K | ﹤0.01% |
65,074
+5,331
| +9% | +$9.49K |
|
3520
Erasca
ERAS
$6.15B
| $102K | ﹤0.01% |
37,381
+4,570
| +14% | +$12.9K |
|
3521
Arq
ARQ
$83.3M
| $102K | ﹤0.01% |
17,356
+442
| +3% | +$2.69K |
|
3522
Intuitive Machines
LUNR
$1.83B
| $100K | ﹤0.01% |
12,423
-20,428
| -62% | -$102K |
|
|
SCPH
3523
DELISTED
scPharmaceuticals
SCPH
| $98.2K | ﹤0.01% |
21,541
-1,117
| -5% | -$5.4K |
|
|
NIU
3524
Niu Technologies
NIU
$200M
| $95.7K | ﹤0.01% |
41,601
-43
| -0.1% | -$83 |
|
3525
Stem
STEM
$44.3M
| $94.4K | ﹤0.01% |
13,561
-122,202
| -90% | -$1.92M |
|
Similar funds
Invesco's Q3 2024 Portfolio in Review
As of Q3 2024, Invesco held 3,952 positions worth $518B, up 9.5% from $473B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Invesco's Q3 2024 filing shows 81 new, 1,757 increased, 1,790 reduced and 200 closed positions. Its largest new stake was iShares 3-7 Year Treasury Bond ETF: 6,397,900 shares worth $765M. The largest sale was Advanced Micro Devices, an estimated $425M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q3 2024 buy was iShares 3-7 Year Treasury Bond ETF: 6,397,900 shares worth $765M.
- Invesco added most to Apple in Q3 2024, an estimated $991M increase.
- Invesco's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $425M.
- Invesco fully exited WestRock Company in Q3 2024, selling an estimated $196M.
- Invesco's ten largest holdings make up 18% of its $518B portfolio in Q3 2024.
- Invesco opened 81 new positions and closed 200 in Q3 2024.
- Invesco's portfolio value rose 9.5% quarter-over-quarter to $518B.
Based on Invesco's 13F filing for Q3 2024, filed 12 Nov 2024.